Table 2.
RAPT domain and definition | Possible challenge | Possible focus of a pilot for an ePCT |
---|---|---|
1. Implementation protocol: Is the protocol sufficiently detailed to be replicated? | Investigators may be uncertain as to how to implement an existing protocol using an embedded approach and how to measure fidelity. | Partner with HCS provider sites to test the feasibility of staff incorporating the protocol into their workflow; have supervisors review routinely captured clinical notes to ascertain fidelity to the protocol and implementation. |
2. Evidence: To what extent does the evidence base support intervention’s efficacy? | At a minimum, a pilot must start with an intervention previously tested in a randomized clinical trial and be efficacious. Investigators may want to test the intervention in a new setting. | Evaluate the feasibility of conducting an ePCT by consulting with leadership and staff methods of randomization, sample size, and other design considerations. |
3. Risk: Is it known how safe the intervention is? | At a minimum, an intervention’s risks must be known and low and plan to monitor risks. | Develop a plan to record and address any adverse event (e.g., if a patient falls). |
4. Feasibility: To what extent can the intervention be implemented under existing conditions? | Investigators may be engaging with new partners or sites or using embedded methods for the first time. | Evaluate feasibility of the intervention when implemented by provider staff at partner sites, if and how changes in policy or practice impact implementation. |
5. Measurement: To what extent can the intervention’s outcome be captured? | Administrative and clinical data may not capture outcomes of interest or be readily accessible to researchers. | Identify measures used by HCSs; examine how new measures can be integrated into routine workflow. Use mixed methods to overcome measurement limitations. |
6. Cost: How likely is the intervention to be economically viable? | Prior studies may have limited data on cost-effectiveness or policies and practices that impact cost-effectiveness may have changed. | Consult with stakeholders to identify potential resource issues, including staff time for training and implementation, and derive business case for intervention. |
7. Acceptability: How willing are providers to adopt the intervention? | At a minimum, an intervention must be acceptable to HCS partners. However, often acceptability is ascertained by engaging HCS leaders and not the frontline staff responsible for implementation. | Conduct qualitative interviews with provider staff responsible for implementing the intervention, supervisors, and leadership. |
8. Alignment: To what extent does the intervention align with external stakeholders’ priorities? | Stakeholders may have previously stated that an intervention aligns with priorities, but priorities can change over time as new policies and practices are enacted. | Incorporate stakeholder-engaged methods to obtain ongoing input as to how intervention processes align with stakeholder values, goals, and mission. |
9. Impact: How useful will the intervention’s results be to different stakeholders? | Questions about how results of the pilot study can inform care or policy. | Incorporate stakeholder-engaged methods to develop active dissemination strategies for key audiences. |
Abbreviations: ePCT, embedded pragmatic clinical trial; HCS, healthcare system; RAPT, Readiness Assessment for Pragmatic Trials.